+ Watch CROX
on My Watchlist
The Company designs, manufactures and markets footwear for men, women and children under the crocs brand.
This company is going to be managed for profitability instead of growth now that Blackstone is calling the shots.
Balance sheet is nice, but revenues keep going down and down. It takes a couple of quarters and Crocs will be in loss.Also, the recent Blackstone deal is silly: Let's sell shares worth of $200M to co-finance share repurchase program. What a weird strategy!
S&P has fair market calculation at 19.60 October 29, 2013. I think their buy back of shares will enhance their earnings along with increased Asian and European markets.
Operations support peer-like profitability while valuation suffers. The stock is punished on currency issues in Japan (dollar-nominated sales dropped) while new countries are added to the list. Seasonal, good momentum to buy in. 12.
it is studdering to get on track
Patent tech with new product lines. Under-appreciated due to current brand association with ugly clogs.
Given the beaten down shares and solid financial position of this company, hard to not be a fan. Understand that popularity of their brand of shoes has gone down, but do we all think the company is not working to expand revenue streams or boost sales? I think buyers now will be very happy in 3-5 years. I'm walking away with CROX!
Low P/E. Low, Low Debt/Equity. Hated stock. Contrarian value. Good ROI.
I shorted Crox in Caps (perhaps my only short ever) when it was at sky high valuations and yet growth prospects were waning. But now after the last walloping the stock took it looks sufficiently cheap enough to think it will outperform. Plus the business doesn't seem to be doing too badly. So I'm voting that investors have overreacted.
22% plunge today:When the market zigs, I zag
Market Overreaction. Strong balance sheet
"Interesting Moves at Crocs" (Fool video) By Matt Thalman http://www.fool.com/investing/general/2013/07/11/interesting-moves-at-crocs.aspx
Crocs has revamped its brand and line up of both its flagship clogs and now shoes--and is well positioned to outperform its peer group of comparables and the S&P 500 over the next year.
EP Top Pick
In march 2012 CROX was trading over $20 per share. Crox was hit in Europe and Japan by a weak retail market last year. I am expecting a rebound in Crox to outperform the S&P 500 over the next year.
P/E 9, solid cash balance, new vast line of SKU should help drive the margins higher with more aggregated value.
Like the long-term prospects of this company that is growing with no debt.
Great company with great products, undervalued
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions